Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
On January 19, 2022, Alset EHome International Inc. (the "Company") received a
notification letter from the Listing Qualifications Department of The Nasdaq
Stock Market LLC ("Nasdaq") notifying the Company that, because the closing bid
price for the Company's common stock listed on Nasdaq was below $1.00 for 30
consecutive trading days, the Company no longer meets the minimum bid price
requirement for continued listing on The Nasdaq Capital Market under Nasdaq
Marketplace Rule 5550(a)(2), requiring a minimum bid price of $1.00 per share
(the "Minimum Bid Price Requirement").
The notification has no immediate effect on the listing of the Company's common
stock. In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company has
a period of 180 calendar days from January 19, 2022, or until July 18, 2022, to
regain compliance with the Minimum Bid Price Requirement. If at any time before
July 18, 2022, the bid price of the Company's common stock closes at or above
$1.00 per share for a minimum of 10 consecutive business days, Nasdaq will
provide written notification that the Company has achieved compliance with the
Minimum Bid Price Requirement.
The notification letter also disclosed that in the event the Company does not
regain compliance with the Minimum Bid Price Requirement by July 18, 2022, the
Company may be eligible for additional time. To qualify for additional time, the
Company would be required to meet the continued listing requirement for market
value of publicly held shares and all other initial listing standards for The
Nasdaq Capital Market, with the exception of the bid price requirement, and
would need to provide written notice of its intention to cure the deficiency
during the second compliance period, by effecting a reverse stock split, if
necessary. If the Company meets these requirements, Nasdaq will inform the
Company that it has been granted an additional 180 calendar days to regain
compliance. However, if it appears to the staff of Nasdaq (the "Staff") that the
Company will not be able to cure the deficiency, or if the Company is otherwise
not eligible, the Staff would notify the Company that its securities will be
subject to delisting. In the event of such notification, the Company may appeal
the Staff's determination to delist its securities, but there can be no
assurance the Staff would grant the Company's request for continued listing.
The Company intends to continue actively monitoring the bid price for its common
stock between now and July 18, 2022 and will consider available options to
resolve the deficiency and regain compliance with the Minimum Bid Price
Requirement.
© Edgar Online, source Glimpses